Dare Bioscience, Inc.
NASDAQ: DARE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sabrina Martucci Johnson
- Employees
- 23
- Headquarters
- San Diego, United States
- IPO year
- 2014
- Market cap
- $19.8M
- Website
- https://darebioscience.com
Loading DARE…
Loading profile data…Frequently asked questions about DARE
What does Dare Bioscience, Inc. (DARE) do?
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal con...
Where does DARE trade?
Dare Bioscience, Inc. (DARE) trades on the NASDAQ.
What sector is DARE in?
Dare Bioscience, Inc. (DARE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Dare Bioscience, Inc.?
Sabrina Martucci Johnson is the chief executive officer of Dare Bioscience, Inc. (DARE).
Where is Dare Bioscience, Inc. headquartered?
Dare Bioscience, Inc. is headquartered in United States.
Does DARE pay a dividend?
Dare Bioscience, Inc. (DARE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DARE go public?
Dare Bioscience, Inc. (DARE) completed its initial public offering in 2014.